摘要
目的调查某院人血白蛋白使用情况,为建立人血白蛋白合理使用管控体系提供依据和参考.方法：回顾性调查2013年1-6月份某院使用人血白蛋白的5257份病例并统计分析,随机抽取每月30份共180份病例进行合理性评价.结果：该院白蛋白使用率为11.8%,白蛋白费用占药品总费用9.4%.180份点评的病例中合理率46.1%.结论：该院人血白蛋白使用存在一定的不合理性,建议制定人血白蛋白合理使用规范,促进临床合理用药.
Objective: To investigate the clinical use of human serum albumin(HAS) as the basis and reference for building up a system to manage and monitor the use of HSA. Methods: A retrospective study that included 5257 patients receiving HSA in our hospital was performed from January to June 2013, 180 records were selected randomly and evaluated for rationality. Results: The utilization rate of HSA was11.8%, HSA cost account for 9.4% of the total cost of all drugs, the rational rate of HSA use was 46.1%.Conclusion: There was some irrational use of HSA in this hospital; a system to manage and monitor the use of HSA should be established to promote rational drug use.
出处
《药学与临床研究》
2015年第6期581-583,共3页
Pharmaceutical and Clinical Research
基金
江苏省药学会-百特生物药学基金项目(JS2012-02)
关键词
人血白蛋白
合理用药
分析
Human serum albumin
Rational use of drugs
Analysis
